Weekly ‘Recall Roundup’
~The Food and Drug Administration announced a recall for one lot of Vitruvias Therapeutics Inc.'s thyroid tablets as they are "superpotent" and can cause hyperthyroidism. In a recall notice Monday, the company said its thyroid tablets, USP 30 mg with the lot number 504950, were potentially superpotent. Those at greater risk are the elderly, pregnant women and infants, especially if consumed over extended periods of time. The recalled lot was […]